This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Immunomedics Inc (IMMU)

NASDAQ: Health Care

Company Balance Sheet
Jun 2013 Jun 2012 Jun 2011 Jun 2010
Cash and Equivalents 41.33M 32.84M 27.10M 29.53M
Receivables 1.25M 1.05M 1.71M 1.20M
Inventories 1.03M 415.88K 289.60K 534.71K
Other Current Assets 1.18M 593.90K 644.70K 329.93K
Total Current Assets 45.22M 35.48M 30.26M 33.00M
Property, Plant & Equipment, Gross 28.83M 28.24M 27.67M 27.06M
Accumulated Depreciation & Depletion 26.74M 25.71M 24.21M 22.73M
Property, Plant & Equipment, Net 2.09M 2.53M 3.46M 4.33M
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 624.83K 628.29K 611.00K 8.79M
Total Non-Current Assets 2.71M 3.16M 4.07M 13.12M
Liabilities & Shareholder Equity
Total Assets 47.93M 38.64M 34.32M 46.12M
Accounts Payable 980.00K 512.00K 5.55M 4.42M
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 0.00 0.00 0.00 0.00
Total Current Liabilities 9.95M 5.59M 5.55M 4.42M
Long Term Debt 0.00 0.00 0.00 0.00
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 1.40M 1.30M 1.13M 979.28K
Minority Interest -104.76K -113.57K -173.99K 0.00
Total Non-Current Liabilities 1.02M 1.01M 960.51K 979.28K
Total Liabilities 10.96M 6.61M 6.51M 5.40M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 36.97M 32.03M 27.82M 40.72M
Common Par 828.41K 755.97K 754.63K 0.00
Additional Paid In Capital 265.69M 248.74M 245.02M 242.91M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -229.25M -217.09M -217.90M -202.83M
Treasury Stock -458.37K -458.37K -458.37K -458.37K
Other Equity Adjustments 161.83K 80.16K 394.67K 1.09M
Total Capitalization 36.97M 32.03M 27.82M 40.72M
Total Equity 36.97M 32.03M 27.82M 40.72M
Total Liabilities & Stock Equity 47.93M 38.64M 34.32M 46.12M
Total Common Shares Outstanding 82.81M 75.60M 75.46M 75.30M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 34.72K 34.72K 34.72K 34.72K
Basic Weighted Shares Outstanding 78.04M 75.48M 75.31M 75.20M
Diluted Weighted Shares Outstanding 78.04M 76.17M 75.31M 75.99M
Number of Employees 119 124 121 122
Number of Part-Time Employees 0 0 0 0

IMMU Immunomedics Inc

Analysts Ratings for IMMU

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 1 2 3 3
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

Brokerage Partners

IMMU Chatter

Select the service that is right for you!

Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs